Clinical Trials on Prolidase-mangel

Total 2056 results

University of Michigan Rogel Cancer Center

Active, not recruiting

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
Incyte Corporation

Withdrawn

A Study of Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma (CITADEL-310)

Mantle Cell Lymphoma
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma

Lymphoma

United States
University of Wisconsin, Madison

Completed

Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
M.D. Anderson Cancer Center
Onyx Therapeutics, Inc.

Terminated

A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma

United States
Celgene

Completed

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial (EMERGE)

Mantle Cell Lymphoma

United States, France, Belgium, Austria, Israel, Singapore, Spain, United Kingdom, Hungary, Colombia, Germany, Italy, Turkey, Puerto Rico
French Innovative Leukemia Organisation
Lymphoma Study Association

Completed

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

Mantle Cell Lymphoma

France
Lund University Hospital
Mundipharma Pte Ltd.; Roche Pharma AG; Celgene

Completed

Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma. (LENA-BERIT)

Mantle Cell Lymphoma

Finland, Denmark, Norway, Sweden
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Lymphoma

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Lymphoma

United States
Milton S. Hershey Medical Center

Unknown

Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)

Mantle Cell Lymphoma

United States
Tingbo Liu
Union hospital of Fujian Medical University

Unknown

The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell Lymphoma

Mantle Cell Lymphoma
French Innovative Leukemia Organisation
Mundipharma Pte Ltd.; Roche Pharma AG; Janssen-Cilag Ltd.; Lymphoma Study Association and other collaborators

Completed

Study of Mantle Cell Lymphoma Treatment by RiBVD (RIBVD)

Mantle Cell Lymphoma

France
University of Miami

Completed

R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma

Lymphoma

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

Lymphoma | Mantle Cell Lymphoma

United States
Pfizer

Completed

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) (OPTIMAL)

Lymphoma

Canada, United States, Spain, Austria, Poland, Sweden, China, Belgium, France, Germany, Italy, United Kingdom, Netherlands, Argentina, Switzerland, Chile, Australia, Brazil
Duke University

Completed

Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell Lymphoma

Mantle Cell Lymphoma
University of Southern California

Terminated

Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma

Lymphoma
Piramal Enterprises Limited

Terminated

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States, India
Oslo University Hospital

Completed

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

Mantle Cell Lymphoma

Norway
CABYC
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Completed

Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) (LCM-04-02)

Mantle Cell Lymphoma

Spain
M.D. Anderson Cancer Center
Biogen

Completed

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

Lymphoma, Mantle-Cell

United States
[Redacted]

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA] (FRONTIER)

Primary Open Angle Glaucoma | Open Angle Glaucoma | Pseudoexfoliation Glaucoma | Pigmentary Glaucoma

United States, Germany, Italy, Philippines, Spain, United Kingdom
Julie Dawson

Completed

RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery. (CMO)

Open Angle Glaucoma and Cataract

United Kingdom
Hacettepe University

Completed

Examining Factors Influencing Thoracolumbar Mobility in Runners

Range of Motion | Mobility | Fascia | Runners

Turkey
Dr Konstantinos Gerasimidis

Completed

Development of an Optimal Micronutrient Reference Range for Adults (OMIS)

Micronutrients Reference Interval | Micronutrients Normal Range

United Kingdom
Glaukos Corporation

Active, not recruiting

Travoprost Intraocular Implant in Conjunction With Cataract Surgery

Ocular Hypertension | Open Angle Glaucoma

Armenia
Isarna Therapeutics GmbH

Completed

Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy

Primary Open Angle Glaucoma

Germany
American Society Of Thermalism And Climatology Inc

Unknown

Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. (GME)

Primary Open Angle Glaucoma | Hypertension Ocular

United States
Glaukos Corporation

Completed

Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) (SL)

Glaucoma | Glaucoma, Open-Angle | Eye Diseases

Spain, France, Austria, Italy, Armenia, Germany, Greece, Poland, United Kingdom
Sooft Italia

Withdrawn

Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops

Primary Open Angle Glaucoma | Intraocular Pressure

Italy
Medical University of Vienna

Terminated

Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular Pressure

Primary Open Angle Glaucoma | Pseudoexfoliative Glaucoma
Lv Yingjuan

Completed

Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma

Vitamin D Deficiency | Primary Open- Angle Glaucoma

China
Centre Hospitalier Universitaire, Amiens
Central Hospital Saint Quentin

Recruiting

Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma (EII)

POAG | MIGS

France
New World Medical, Inc.

Completed

A Comparison of Two Ab Interno Procedures in the Treatment of Glaucoma in Patients Undergoing Cataract Extraction

Open Angle Glaucoma

United States
Sight Sciences, Inc.

Unknown

Use of the OMNI® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma

Open Angle Glaucoma

United States
Croma-Pharma GmbH

Completed

Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy

Cataract | Open Angle Glaucoma

Austria
CHU de Quebec-Universite Laval
Pfizer; Canadian Glaucoma Clinical Research Council

Completed

Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma (SLT)

Glaucoma | Inflammatory Response

Canada
Glaukos Corporation

Completed

A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma (SY)

Glaucoma | Glaucoma, Open-Angle | Eye Diseases

Spain, France, Armenia, Germany, Austria, Italy
Sooft Italia

Withdrawn

Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy

Primary Open Angle Glaucoma | Intraocular Pressure

Italy
IOPtima Ltd.

Unknown

Evaluation of OT-135P (IOPtiMateTM) : Beam Manipulating System for CO2 Laser Assisted Non-Penetrating Glaucoma Surgery

Open Angle Glaucoma | Pseudo-Exfoliative Glaucoma

Israel
National Taiwan University Hospital Hsin-Chu Branch
Local clinic

Recruiting

Microinvasive Glaucoma Surgery -The Lowering Effect of Intraocular Pressure on Glaucoma Patients With High Frequency Deep Sclerotomy (HFDS)

Primary Open Angle Glaucoma | Intraocular Pressure | Glaucoma Surgery

Taiwan
Nicox Ophthalmics, Inc.

Recruiting

MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)

Ocular Hypertension | Open Angle Glaucoma

United States, China
iSTAR Medical

Recruiting

MINIject Global Long-Term Follow-up Study (STAR-GLOBAL)

Ocular Hypertension | Open Angle Glaucoma

Germany, Spain, Colombia, France, India, Panama
Theratocular Biotek Co.
Novotech (Australia) Pty Limited

Active, not recruiting

A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

Australia
Ocuphire Pharma, Inc.

Completed

Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma

Ocular Hypertension | Open Angle Glaucoma

United States
Sanoculis Ltd

Completed

Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study

Primary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative Glaucoma

Israel
Ocular Therapeutix, Inc.

Completed

Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT

Ocular Hypertension | Open Angle Glaucoma

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

Glaucoma, Open-angle

Slovakia

3

Subscribe